PARP inhibitors elicit a cellular senescence mediated inflammatory response in homologous recombination proficient cancer cells
Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors have improved the prognosis of homologous recombination deficient (HRD) ovarian cancer (OC), while effective therapeutic strategies for HR-proficient (HRP) OC still need to be established. This study investigates senescence-mediated inflammatio...
Saved in:
| Main Authors: | Misato Kamii, Ryo Kamata, Hitoshi Saito, Gaku Yamamoto, Chiaki Mashima, Toyohiro Yamauchi, Takehiro Nakao, Yuta Sakae, Tomoko Yamamori-Morita, Kazuki Nakai, Yumi Hakozaki, Masataka Takenaka, Aikou Okamoto, Akihiro Ohashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00336-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ADP-ribose hydrolases: biological functions and potential therapeutic targets
by: Jingpeng Wang, et al.
Published: (2024-01-01) -
The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments – parallels with other neurodegenerative disorders
by: Dahlia A. Ordaz, et al.
Published: (2025-06-01) -
Resveratrol Inhibits Nucleosome Binding and Catalytic Activity of PARP1
by: Daria O. Koshkina, et al.
Published: (2024-11-01) -
Impact of Poly(ADP-Ribose) Polymerase (PARP) and Immune Checkpoint Inhibitor Combinations on the Viability of Triple-Negative Breast Cancer Cells
by: Tusha Sharma, et al.
Published: (2024-04-01) -
PARP inhibitors are a new area in the treatment of breast cancer
by: V. P. Letyagin
Published: (2014-08-01)